2008   |   2007   |   2006   |   2005   |   2004   |   2003   |   2002   |   2001   |   2000
 

 
Melville, New York, November 13, 2001
Bovie Medical Corporation (the Company) (OTC Bulletin Board: BOVI), a manufacturer and marketer of electrosurgery products today announced financial results for the third quarter and nine month periods for fiscal 2001.
 
Revenues for the three months ended September 30, 2001 increased to a record $2.7 million from $2.5 million last year. Net income for the period was $312,308 or $.02 per share, diluted, versus net income of, $149,660 or $.01 per share, diluted, for the comparable period a year-earlier.
 
Revenues for the nine months ended September 30, 2001 increased 16% to $8.2 million from $7.1 million for the same period a year ago. Net income for the nine months of fiscal 2001 was $500,748 or $.03, per share diluted, compared to $465.640 or $.03, per share diluted in the same period of FY 2000.
 
Andrew Makrides, president of Bovie Medical Corporation stated, "We continue to experience increased demand for our electrosurgical generators and our strong performance during the first nine months of FY 2001 has continued into the fourth quarter, witnessed by October sales reaching an historic level of $1.2 million."
 
He added, "Management is encouraged by the progress on its J-Plasma technology, a cold plasma surgical device emitting a highly controlled thin focused beam of ionized gas, void of conductive current, allowing for minimal invasiveness to the patient during surgical procedures."
 

---

 
Melville, New York, August 20, 2001
Bovie Medical Corporation (the Company) (OTC Bulletin Board: BOVI), a manufacturer and marketer of electrosurgery products today announced its financial results for the second quarter and six month results for fiscal 2001.
 
Revenues for the three months ended June 30, 2001 increased 16% to a record $2.81 million from $2.43 million a year ago. Net income for the period was $102,589 or $.01 per share versus net income of $259,000 or $.02 per share for the comparable period a year-earlier.
 
Revenues for the six months ended June 30, 2000 increased 21% to $5.55 million from $4.6 million for the same period a year ago. Net income for the six months of fiscal 2001 was $188,440 or $.01 per share compared to $315,000 or $.02 per share in 2000.
 
Revenues continued to be positively impacted by the Company's ability to penetrate the electrosurgical generator marketplace. Net income was negatively impacted by an increase in overall expenses, particularly in the area of new product development and quality control personnel.
 
Andrew Makrides, president of Bovie Medical Corporation stated, "Our record revenues during the quarter reflects the strong growth and continued market penetration of our electrosurgical generators."
 
The Company also reported that its joint venture made substantial progress towards the commercialization of J-Plasma: an innovative patented electrosurgical technology that uses inert gases to affect precise surgical procedures.
 

---

 
Melville, New York, May 21, 2001
Bovie Medical Corporation (the Company) (OTC: BB: BOVI), a manufacturer and marketer of electrosurgery products today announced first quarter financial results for the period ended March 31, 2001. For the first three months of FY 2001, revenues increased 25 percent to a record $2.73 million, resulting in a record first quarter net income of $85,851 or $.01 cents per share.
 
Andrew Makrides, president of Bovie Medical Corporation stated, " We continue to experience positive sales growth from both our electrosurgical generator and our cauteries business lines. Due to the current trend within the medical community for less-invasive procedures using lower wattage and more versatile generators, management remains optimistic about the Company's future growth potential."
 
In addition, the Company also announced that a definitive agreement was signed with SouthTrust Bank for a $1.5 million credit facility; representing a significant increase from the Company's previous line of credit. SouthTrust Corporation (NASDAQ: SOTR) is a $46 billion in assets bank holding company headquartered in Birmingham, Alabama.
 

---

 
Melville, New York, April 10, 2001
Bovie Medical Corporation (the Company) (OTC: BB: BOVI), a manufacturer and marketer of electrosurgery products today announced that revenues for the recently completed first quarter ended March 31, 2001 were the strongest first quarter in the Company's history; rising approximately 20 percent over the same period last year.
 
Higher electrosurgical generator sales contributed significantly to the improved first quarter results. It is estimated that the electrosurgery industry is currently growing 10 percent annually and is used in over 80 percent of all surgical procedures performed worldwide. For the first three months of FY 2000, revenues totaled $2.17 million. The Company expects to report first quarter financial results in mid-May.
 

---

 
Melville, New York, March 29, 2001
Bovie Medical Corporation (the Company) (OTC: BB: BOVI), a manufacturer and marketer of electrosurgery products today announced results for the fiscal year ended December 31, 2000. Revenues increased to a record $9.90 million from $9.60 million in the prior year; resulting in a turnaround in net income totaling $500,600 or $.04 cents per share versus a net loss of $(2,183,839) or a loss of $(.13) cents per share.
 
Andrew Makrides, president of Bovie Medical Corporation stated, "Fiscal 2000 marked a record year in sales and earnings. As we continue to increase our presence in the expanding electrosurgery market, we are encouraged by the continued increase in demand for our products during the first quarter of the current fiscal year."
 
Mr. Makrides added, "We remain committed to actively developing new products including new generators to compliment our extensive line of surgical generators. Furthermore, we continue to be encouraged by our progress with the development of the J-Plasma technology and remain optimistic about the technology's potential."
 

---

 
Melville, New York January 10, 2001
Bovie Medical Corporation (the Company) (OTC: BB: BOVI), a manufacturer and marketer of electrosurgical products announced today that the United States Food and Drug Administration (FDA) has approved the 510(k) application to market the Bovie 1250, a 120 watt powered generator for use in such areas as: general surgery, gynecology, plastic surgery and other minimally invasive surgical procedures.
 
The Company anticipates shipping the first Bovie 1250s within 30 days and expects sales from the 1250 to be a leading contributor to increased electrosurgical revenues in fiscal year 2001. In reviewing the past year, management preliminarily expects to announce record revenues for fiscal year 2000. With the forecast of increased electrosurgical generator sales for fiscal year 2001, management is extremely optimistic about revenue growth for the upcoming year.
 
Bovie Medical Corporation is engaged in the engineering, manufacturing and marketing of electrosurgical medical products.